| # | Title | Journal | Year | Citations |
|---|
| 1 | Bacterial Biofilm and its Role in the Pathogenesis of Disease | Antibiotics | 2020 | 465 |
| 2 | Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity | Antibiotics | 2018 | 428 |
| 3 | Development and Challenges of Antimicrobial Peptides for Therapeutic Applications | Antibiotics | 2020 | 318 |
| 4 | Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens | Antibiotics | 2015 | 312 |
| 5 | Global Trends in Antimicrobial Use in Food Animals from 2017 to 2030 | Antibiotics | 2020 | 282 |
| 6 | Drug Resistance Mechanisms in Mycobacterium tuberculosis | Antibiotics | 2014 | 272 |
| 7 | Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017) | Antibiotics | 2018 | 240 |
| 8 | Livestock-Associated MRSA: The Impact on Humans | Antibiotics | 2015 | 237 |
| 9 | Bacteriophages and Biofilms | Antibiotics | 2014 | 236 |
| 10 | Candidiasis and Mechanisms of Antifungal Resistance | Antibiotics | 2020 | 231 |
| 11 | Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen | Antibiotics | 2020 | 230 |
| 12 | Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance | Antibiotics | 2021 | 206 |
| 13 | Bacteria from Animals as a Pool of Antimicrobial Resistance Genes | Antibiotics | 2017 | 184 |
| 14 | Antibiotic Discovery: Where Have We Come from, Where Do We Go? | Antibiotics | 2019 | 184 |
| 15 | Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections | Antibiotics | 2019 | 183 |
| 16 | The Continuing Threat of Methicillin-Resistant Staphylococcus aureus | Antibiotics | 2019 | 176 |
| 17 | Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile? | Antibiotics | 2020 | 172 |
| 18 | Anti-Fungal Efficacy and Mechanisms of Flavonoids | Antibiotics | 2020 | 165 |
| 19 | Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance | Antibiotics | 2013 | 151 |
| 20 | Biocidal Agents Used for Disinfection Can Enhance Antibiotic Resistance in Gram-Negative Species | Antibiotics | 2018 | 145 |
| 21 | Antimicrobial Usage and Antimicrobial Resistance in Animal Production in Southeast Asia: A Review | Antibiotics | 2016 | 144 |
| 22 | Do Iron Oxide Nanoparticles Have Significant Antibacterial Properties? | Antibiotics | 2021 | 143 |
| 23 | Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria | Antibiotics | 2019 | 139 |
| 24 | Phenotypic Resistance to Antibiotics | Antibiotics | 2013 | 134 |
| 25 | Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria | Antibiotics | 2015 | 131 |
| 26 | From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials | Antibiotics | 2016 | 131 |
| 27 | Acinetobacter baumannii Resistance: A Real Challenge for Clinicians | Antibiotics | 2020 | 131 |
| 28 | Antimicrobial Usage in Animal Production: A Review of the Literature with a Focus on Low- and Middle-Income Countries | Antibiotics | 2018 | 129 |
| 29 | The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria | Antibiotics | 2020 | 129 |
| 30 | Fosfomycin: Pharmacological, Clinical and Future Perspectives | Antibiotics | 2017 | 127 |
| 31 | Bacteriophages: Protagonists of a Post-Antibiotic Era | Antibiotics | 2018 | 127 |
| 32 | Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus | Antibiotics | 2013 | 126 |
| 33 | Trends, Epidemiology, and Management of Multi-Drug Resistant Gram-Negative Bacterial Infections in the Hospitalized Setting | Antibiotics | 2020 | 126 |
| 34 | Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium | Antibiotics | 2020 | 125 |
| 35 | Antimicrobial Peptides: A Potent Alternative to Antibiotics | Antibiotics | 2021 | 125 |
| 36 | It’s Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa | Antibiotics | 2021 | 123 |
| 37 | Bacteriophages as Alternatives to Antibiotics in Clinical Care | Antibiotics | 2019 | 122 |
| 38 | Characterization of Antibiotic and Biocide Resistance Genes and Virulence Factors of Staphylococcus Species Associated with Bovine Mastitis in Rwanda | Antibiotics | 2020 | 120 |
| 39 | Endophytic Streptomyces laurentii Mediated Green Synthesis of Ag-NPs with Antibacterial and Anticancer Properties for Developing Functional Textile Fabric Properties | Antibiotics | 2020 | 120 |
| 40 | A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies | Antibiotics | 2022 | 120 |
| 41 | Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Outpatients—A Systematic Review and Meta-Analysis | Antibiotics | 2017 | 119 |
| 42 | Concepts and Methods to Access Novel Antibiotics from Actinomycetes | Antibiotics | 2018 | 119 |
| 43 | Phages for Biofilm Removal | Antibiotics | 2020 | 119 |
| 44 | Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic | Antibiotics | 2021 | 118 |
| 45 | Old and New Glycopeptide Antibiotics: Action and Resistance | Antibiotics | 2014 | 116 |
| 46 | The Pros and Cons of the Use of Laser Ablation Synthesis for the Production of Silver Nano-Antimicrobials | Antibiotics | 2018 | 115 |
| 47 | Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care | Antibiotics | 2018 | 115 |
| 48 | Metal Complexes, an Untapped Source of Antibiotic Potential? | Antibiotics | 2020 | 115 |
| 49 | Plant Secondary Metabolites in the Battle of Drugs and Drug-Resistant Bacteria: New Heroes or Worse Clones of Antibiotics? | Antibiotics | 2020 | 115 |
| 50 | Food Safety through Natural Antimicrobials | Antibiotics | 2019 | 114 |
